FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the use of 3-(1-{3-[5-(1-methylpiperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydropyridazin-3-yl)-benzonitrile or a pharmaceutically acceptable salt and/or solvate thereof.
EFFECT: manufacture of a medicament for the treatment of hepatocellular carcinoma (HCC).
4 cl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION OF 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTICOLIC ACTIVITY, WITH MEK INHIBITOR | 2013 |
|
RU2684407C2 |
| COMBINATION OF 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTICANCER ACTIVITY WITH QUINAZOLINE DERIVATIVE | 2015 |
|
RU2704120C2 |
| PHARMACEUTICAL PREPARATION | 2020 |
|
RU2822063C2 |
| 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND VARIANTS OF THEIR USE | 2018 |
|
RU2795850C2 |
| PRODRUGS OF HIV REVERSE TRANSCRIPTASE INHIBITORS | 2015 |
|
RU2693622C2 |
| PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS TAM AND MET KINASE INHIBITORS | 2019 |
|
RU2773611C1 |
| PYRIDINONE PYRIDAZINONE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP) | 2007 |
|
RU2472782C2 |
| CYANOQUINOLINE DERIVATIVES | 2011 |
|
RU2600928C2 |
| 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ZINC FINGER PROTEIN 2 (IKZF2) OF THE IKAROS FAMILY | 2019 |
|
RU2797559C2 |
| SWEET TASTE AND FLAVOUR MODIFIER | 2013 |
|
RU2666534C2 |
